WCN25-1136 FRAILTY IN CKD

WCN25-1136 FRAILTY IN CKD

Saved in:

Bibliographic Details
Main Authors:	Beatriz Mendes, António Inácio, Ana Piedade, Francisca Fonseca, Ana Farinha, Karina Soto
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924022150
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-1084 INTERNATIONAL RISK-PREDICTION TOOL IN IgAN AND THE PROGNOSTIC IMPLICATIONS OF CRESCENTS
by: Beatriz Mendes, et al.
Published: (2025-02-01)

WCN25-1069 WHEN THE ANSWER IS IN THE URINARY SEDIMENT
by: Beatriz Mendes, et al.
Published: (2025-02-01)

WCN24-2308 WHAT TO EXPECT WHEN DIAGNOSING ANCA-ASSOCIATED VASCULITIS? A PORTUGUESE CENTER PERSPECTIVE AND EXPERIENCE
by: António Inácio, et al.
Published: (2024-04-01)

WCN24-1136 URINE SINGLE-CELL RNA-SEQUENCING IN MINIMAL CHANGE DISEASE
by: Yaacov Frishberg, et al.
Published: (2024-04-01)

WCN24-283 CAN SERUM AND HISTOLOGIC BIOMARKERS PREDICT KIDNEY AND OVERALL SURVIVAL IN ANCA-ASSOCIATED VASCULITIS?
by: António Inácio, et al.
Published: (2024-04-01)

Hospitaller Castles and Fortifications in the Kingdom of Jerusalem, 1136-1291
by: Denys Pringle
Published: (2023-01-01)

Euglycemic Ketoacidosis in a non-diabetic patient: a rare adverse effect of sodium-glucose co-transporter type-2 inhibitors. A review based on a case report
by: Francisca Fonseca, et al.
Published: (2025-01-01)

WCN25-1690 CODESIGNING AN INFORMATION WEBSITE FOR CKD PATIENTS : RENACLIC
by: corinne isnard bagnis, et al.
Published: (2025-02-01)

WCN25-4537 ORAL MANIFESTATIONS IN CHRONIC KIDNEY DISEASES(CKD)
by: Padmini Sirkanungo, et al.
Published: (2025-02-01)

WCN25-1369 BURDEN AND OUTCOMES OF CKD IN PATIENTS PRESENTING WITH HYPERTENSIVE CRISIS
by: Yelavarthy Yeshwanth Mohan, et al.
Published: (2025-02-01)

WCN25-84 ROLE OF DESIDUSTAT IN ANEMIC CKD-EASTERN INDIA EXPERIENCE
by: Rohit Rungta
Published: (2025-02-01)

WCN25-152 HYDRATION: How Much is Suitable in Every CKD Stage?
by: Dmytro Ivanov, et al.
Published: (2025-02-01)

WCN25-2306 THE BURDEN OF TRAVELLING DISTANCE TO THE DIALYSIS CENTRE ON CKD PATIENTS IN INDIA
by: Deepa Usulumarty, et al.
Published: (2025-02-01)

WCN25-1900 Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
by: Katherine Tuttle, et al.
Published: (2025-02-01)

WCN25-3917 CKD IN HIGH-ENDEMIC REGIONS: COMMUNITY INSIGHTS FROM SELF-REPORTED, NEWLY DIAGNOSED, AND NON-CKD RESIDENTS
by: Kavita Yadav, et al.
Published: (2025-02-01)

WCN25-136 IMPROVE KIDNEY CARE: PERSPECTIVES FROM PEOPLE WITH CKD AND RISK FACTORS FOR CKD ON ACCESS TO AND EXPERIENCE OF NEPHROLOGY SERVICES
by: Rebekah Grace Cheung Judge, et al.
Published: (2025-02-01)

WCN25-2509 GENETIC VARIANTS ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) IN AN INDIAN POPULATION
by: Mythri Shankar, et al.
Published: (2025-02-01)

WCN25-4045 FINANCIAL CHAINS AND MENTAL STRAIN: THE TRUE COST OF HAEMODIALYSIS FOR CKD PATIENTS
by: Mohit Naredi, et al.
Published: (2025-02-01)

WCN25-1595 ORAL HEALTH ASSESSMENT IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS ON MAINTENANCE HEMODIALYSIS
by: Akash Rana, et al.
Published: (2025-02-01)

WCN25-3776 CAN WE IMPROVE ACCURACY OF DIAGNOSING IRON DEFICIENCY AMONG CKD PATIENTS?
by: Nageshwar Panchal, et al.
Published: (2025-02-01)

WCN25-2199 Is there a role for substituting non-vasodilatory beta-blockers in managing hypertension in CKD ?
by: Sayali Kondkar, et al.
Published: (2025-02-01)

WCN25-4211 A COMPARATIVE STUDY OF DESIDUSTAT AND ERYTHROPOIETIN STIMULATING AGENTS IN CKD-RELATED ANEMIA
by: Gaurav Modi, et al.
Published: (2025-02-01)

WCN25-3504 KIM-1-dependent downregulation of DNase-I drives AKI-to-CKD transition
by: Lakshman Gunaratnam, et al.
Published: (2025-02-01)

WCN25-2832 COMPARISON OF ESTIMATED GLOMERULAR FILTRATION RATE IN MEXICAN KIDNEY TRANSPLANT RECIPIENTS: A COMPARATIVE ANALYSIS OF MDRD AND CKD-EPI EQUATIONS
by: Milagros Melissa Flores Fonseca, et al.
Published: (2025-02-01)

Baseline Characteristics of Frailty and Disease Stage in Older People Living With CKD
by: Benignus Logan, et al.
Published: (2025-01-01)

WCN25-2620 CUMULATIVE EFFECTS OF THE ALDOSTERONE SYNTHASE INHIBITOR VICADROSTAT COMBINED WITH EMPAGLIFLOZIN ON ALBUMINURIA IN PEOPLE WITH CKD
by: Peter Rossing, et al.
Published: (2025-02-01)

WCN25-2485 REAL-WORLD EXPERIENCE OF DESIDUSTAT IN CKD-ANEMIA PATIENTS: DATA FROM NORTHEAST INDIA
by: Karan Saraf
Published: (2025-02-01)

WCN25-4132 IL-31 and JAK-STAT Signaling in CKD-aP: Exploring Therapeutic Implication
by: Mohinder Kaur, et al.
Published: (2025-02-01)

WCN25-2742 IMMUNE RESPONSE TO HEPATITIS B VACCINATION IN CKD PATIENTS AND FACTORS ASSOCIATED WITH NON- RESPONSE
by: MD.Nazrul Islam, et al.
Published: (2025-02-01)

WCN25-4014 ASSESSMENT OF PULMONARY FUNCTION THROUGH FORCED OSCILLATION TECHNIQUE (FOT) IN DIFFERENT STAGES OF CKD
by: ALOK KUMAR MOHAPATRA, et al.
Published: (2025-02-01)

WCN25-2548 Role of therapy and predictors retarding disease progression in biopsied CKD patients: An observational study
by: Sourya Sourabh Mohakuda, et al.
Published: (2025-02-01)

Narrative Review: Clinical Implications and Assessment of Frailty in Patients With Advanced CKD
by: Alice L. Kennard, et al.
Published: (2024-04-01)

WCN25-482 Mesenchymal Stem Cell might be a rescue therapy in severe IgA nephropathy with CKD
by: Byoung Soo Cho, et al.
Published: (2025-02-01)

WCN24-2070 Calprotectin Is Associated with Vascular Calcification and Cardiovascular Complications During CKD
by: Serban Ardeleanu, et al.
Published: (2024-04-01)

WCN25-3224 PROGNOSTIC TRAJECTORIES OF KIDNEY FAILURE AND COMPETING RISKS ACROSS CKD STAGES IN PERU: FINDINGS FROM A NATIONAL SURVEILLANCE PROGRAM
by: Jessica Bravo Zúñiga, et al.
Published: (2025-02-01)

Investigating frailty and quality of life in patients with heart failure and CKD (FRAIL study)
by: Izabella Uchmanowicz
Published: (2025-02-01)

WCN25-4217 CORRELATION OF FRAILTY STATUS AND CLINICAL PARAMETHERS IN A PERITONEAL DIALYSIS PATIENTS COHORT
by: Ruben Torres, et al.
Published: (2025-02-01)

Lactobacillus Johnsonii YH1136 alleviates schizophrenia-like behavior in mice: a gut–microbiota–brain axis hypothesis study
by: Liqin Zheng, et al.
Published: (2025-04-01)

WCN25-2005 SEROPREVALENCE OF VARICELLA IgG ANTIBODIES IN ADULT CKD POPULATION IN INDIA AND THEIR IMMUNE RESPONSE TO VARICELLA VACCINATION
by: Shrisha Manjunath Hegde, et al.
Published: (2025-02-01)

WCN25-3304 INCREASED RISK OF HF AND RETINOPATHY WITH ADVANCED CKD BUT NOT WITH ASCVD IN PATIENTS WITH T2D (CITE 2 STUDY)
by: Samit Ghosal, et al.
Published: (2025-02-01)